TheraVab Biosciences Announces Exclusive Option to License Engineered Receptor Immunobiotherapy for the Treatment of Neu
TheraVab Biomedics Pte. Ltd., a pre-clinical stage immunotherapy company that aims at reversal of the inflammatory processes that lead to cancers, neurodegenerative... Read More
Inventors Honored at Virtual Standing InnOvation Event
More than 200 innovators participated in a live-stream event and virtual happy hour to celebrate their achievements in fiscal year 2020. The... Read More
UF Innovate Leaders to Direct Development of Innovation District
University of Florida Office of Research Vice President Dr. David Norton and UF COO Charlie Lane have announced that Jim O’Connell, Assistant... Read More
